Abbott India Limited
Canara Robeco Mutual Fund sold 11,726 shares of Abbott India Limited, reducing its stake from 1.07% to 1.01%.
A leading multinational pharmaceutical company operating in India since 1944, Abbott India manufactures and distributes a comprehensive portfolio of medicines, nutritional products, and diagnostic solutions across the country. The company serves the Indian market through an extensive network of independent distributors, focusing on therapeutic areas including cardiovascular health, gastroenterology, and nutrition. Its integrated operations span research, development, and commercialization of pharmaceutical products tailored to meet diverse Indian healthcare needs and patient requirements.
Joint venture between Canara Bank and Robeco of Netherlands. Manages over Rs 1.5 lakh crore. Canara Robeco Equity Hybrid Fund and Canara Robeco Emerging Equities are among its best-regarded offerings with long consistent track records. Backed by the Canara Bank network for distribution across Tier 2 and Tier 3 India.